TrialBlood2012

Activity of alemtuzumab monotherapy in treatment-naive, relapsed, and refractory severe acquired aplastic anemia.

Phillip Scheinberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.